Legal & General Group’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,908
Closed -$2.29K 3401
2023
Q4
$2.29K Hold
1,908
﹤0.01% 3362
2023
Q3
$1.64K Hold
1,908
﹤0.01% 3404
2023
Q2
$2.29K Buy
+1,908
New +$9.54K ﹤0.01% 3399
2022
Q2
Sell
-1,586
Closed -$8K 3709
2022
Q1
$8K Buy
1,586
+102
+7% +$818 ﹤0.01% 3459
2021
Q4
$19K Buy
1,484
+770
+108% +$11K ﹤0.01% 3299
2021
Q3
$11K Hold
714
﹤0.01% 3437
2021
Q2
$11K Buy
+714
New +$12.5K ﹤0.01% 3415

Legal & General Group's RAIN Position: Q1 2024 in Review

Legal & General Group sold out of Rain Oncology Inc. Common Stock (RAIN) in Q1 2024, closing a stake of 1,908 shares — an estimated $2.29K sold.

Legal & General Group first reported a position in RAIN in Q2 2021 and held it in 7 quarters. The position peaked at $19K in Q4 2021. 0 funds tracked by Wall St. Rank hold RAIN as of Q1 2024.

  • Legal & General Group reported no remaining Rain Oncology Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Legal & General Group sold 1,908 Rain Oncology Inc. Common Stock shares in Q1 2024, an estimated $2.29K.
  • Legal & General Group first reported a position in Rain Oncology Inc. Common Stock in Q2 2021 and held it in 7 quarters.
  • Legal & General Group's Rain Oncology Inc. Common Stock position peaked at $19K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q1 2024.

Based on Legal & General Group's 13F filing for Q1 2024, filed 14 May 2024.